Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioma 5Neuroendocrine Tumors 2Glioblastoma 2Sarcoma 1Parkinson Disease 1Parathyroid Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Multiple Endocrine Neoplasia 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Gliosarcoma 1Glioma, Subependymal 1Ependymoma 1Congenital Hyperinsulinism 1Carcinoma, Medullary 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 4Radiotherapy 4Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3Tamoxifen 2Donepezil 2Cisplatin 2Carboplatin 2Biopsy 2temsirolimus 1sargramostim 1fluorodopa F 18 1entinostat 1carboxyamido-triazole 1aldesleukin 1Vinblastine 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Photochemotherapy 1Pharmacogenomic Testing 1Paclitaxel 1Muromonab-CD3 1Modafinil 1Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Glioma, Subependymal × fluorodopa F 18 × Clear all
NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Mayo Clinic

Phase EARLY_PHASE1 Completed
24 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡